DCPC 230008 - National Comprehensive Cancer Control Program Evaluation (2022 - 2027)

The contract focuses on conducting a comprehensive evaluation of the National Comprehensive Cancer Control Program from 2022 to 2027, led by the Centers for Disease Control and Prevention. The main goals are to carry out a utilization-focused evaluation that enables CDC staff, cancer control program practitioners, and partners to take informed and actionable steps to enhance the program. This evaluation is designed to produce findings that clearly describe the program's capacity, demonstrate its outcomes, and uncover important lessons that will support the program's continued growth and sustainability. The evaluation will provide critical insights that help shape improvements and strategic decision-making in cancer control initiatives. Key contacts for the project include Angela Moore as the program point of contact and a contracting officer yet to be determined. The initiative lacks specific geographic or organizational details but is essential for advancing the effectiveness and impact of the CDC’s comprehensive cancer control efforts across participating states and partners.